Abstract:
OBJECTIVE To investigate the effects of Yiqi Bushen Formula-containing serum on proliferation and metastasis of human gastric cancer cell SGC-7901 and CD44
+EpCAM
+ double positive cancer stem cells ratio.
METHODS The human gastric cancer cell line SGC-7901 was intervened by low, medium and high concentrations of Yiqi Bushen Formula-containing serum and blank serum respectively. The proliferation inhibition rate of 24, 48, 72 h cells was detected by MTT assay. Transwell was used to detect the migration and invasion ability of gastric cancer cells. Gastric cancer stem cells were enriched by co-cultured with 5-fluorouracil (5-Fu). Flow cytometry was used to detect the CD44
+EpCAM
+ double positive cancer stem cells ratio in gastric cancer stem cells after drug intervention.
RESULTS After 48, 72 h intervention, the cell proliferation inhibition rate of the Yiqi Bushen Formula group was significantly higher than that of the negative control group and the blank control group, with a significant difference (
P<0.05). Transwell showed that compared with the negative control group and the blank control group, the number of permeable membrane cells in each group of Yiqi Bushen Formula group decreased significantly, and the migration ability was significantly inhibited, with a significant difference (
P<0.01). Flow cytometry showed that after co-culture with 20 μg·mL
-1 5-Fu, the proportion of stem cells in gastric cancer increased significantly. The CD44
+EpCAM
+ double positive cancer stem cells ratio in each group was down. The middle and high concentration groups was higher than that of the model control group with a significant difference (
P<0.01).
CONCLUSION Yiqi Bushen Formula-containing serum can significantly inhibit the proliferation of human gastric cancer cell SGC-7901, and it is time and dose correlation. Its anti metastasis effect may be related to the down regulation of the expression of CD44 and EpCAM from the surface markers and reduction of the CD44
+EpCAM
+ double positive cancer stem cells ratio in gastric cancer cells.